ARCH Venture Fund IX, L.P. 13D and 13G filings for Sana Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-14 5:12 pm Purchase |
2024-09-30 | 13G | Sana Biotechnology, Inc. SANA |
ARCH Venture Fund IX, L.P. | 46,028,125 20.600% |
1,883,181![]() (+4.27%) |
Filing |
2024-02-09 5:35 pm Purchase |
2023-12-31 | 13G | Sana Biotechnology, Inc. SANA |
ARCH Venture Fund IX, L.P. | 44,144,944 22.400% |
65,536![]() (+0.15%) |
Filing |
2023-02-13 4:07 pm Purchase |
2022-12-31 | 13G | Sana Biotechnology, Inc. SANA |
ARCH Venture Fund IX, L.P. | 44,079,408 23.100% |
817![]() (+0.00%) |
Filing |
2022-02-10 5:12 pm Purchase |
2021-12-31 | 13G | Sana Biotechnology, Inc. SANA |
ARCH Venture Fund IX, L.P. | 44,078,591 23.300% |
44,078,591![]() (New Position) |
Filing |